#18 - Concerning Lack of Virological Suppression in Plasma and Cerebrospinal Fluid in Adolescents on Long-term Early Antiretroviral Therapy - Barbara Laughton

International Workshop on Pediatrics & HIV 2024

#17 - Findings From the Todurujo NA Kadurok (Empowering Youth) HIV Self-Testing and Edutainment Comic Randomized Controlled Trial With Refugee Youth in a Humanitarian Setting in Uganda - Carmen Logie

International Workshop on Pediatrics & HIV 2024

#16 - A Multi-Country Analysis of HIV Testing Strategies for Identifying Adolescents Living With HIV - Deborah Carpenter

International Workshop on Pediatrics & HIV 2024

Update on Analytic Treatment Interruption Consensus Guidelines for HIV Cure/Control - Mark Cotton

International Workshop on Pediatrics & HIV 2024

Update on Cure Agenda - Deborah Persaud

International Workshop on Pediatrics & HIV 2024

From CHER to Cure: How a Pivotal Trial Helped to Shape the HIV Cure/Control Agenda in Children & Adolescents - Mark Cotton

International Workshop on Pediatrics & HIV 2024

#24 - In-Utero Exposure to High Tenofovir Concentration Is Associated With Lower Bone Mineral Content in HIV-Unexposed Infants - Kimesh - Naidoo

International Workshop on Pediatrics & HIV 2024

#23 - Genotypic Resistance to Integrase Inhibitors, Protease Inhibitors and Tenofovir Alafenamide Is Uncommon in Children With Virological Rebound in the CHAPAS-4 Randomised Trial of Second-Line Antiretroviral Therapy for Children With HIV - Cissy Kityo

International Workshop on Pediatrics & HIV 2024

#22 - Trends in Infant HIV Positivity and Linkage to ART among HIV-Exposed Infants Aged <12 Months in PEPFAR-Supported Programs, FY2018-FY2023 - Elizabeth M. Rabold

International Workshop on Pediatrics & HIV 2024

#21- Hospital Outcomes From a Cohort of Mozambican HIV-Exposed Uninfected and HIV-Unexposed Infants - Chris Buck

International Workshop on Pediatrics & HIV 2024